{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:47:32Z","timestamp":1782269252180,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jmgm.2026.109459","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:03:20Z","timestamp":1780531400000},"page":"109459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of novel anaplastic lymphoma kinase inhibitors with enhanced binding interactions for non-small cell lung cancer via in silico approaches and retrospective experimental data support"],"prefix":"10.1016","volume":"147","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109459_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl 3","key":"10.1016\/j.jmgm.2026.109459_bib2","doi-asserted-by":"crossref","first-page":"iii4","DOI":"10.1093\/annonc\/mdw301","article-title":"The role of the ALK receptor in cancer biology","volume":"27","author":"Hallberg","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jmgm.2026.109459_bib3","first-page":"20","article-title":"ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies","volume":"7","author":"Poei","year":"2024","journal-title":"Cancer Drug Resist"},{"issue":"Suppl 3","key":"10.1016\/j.jmgm.2026.109459_bib4","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/annonc\/mdw300","article-title":"The continuum of care for ALK-positive NSCLC: from diagnosis to new treatment options - an overview","volume":"27","author":"Solomon","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jmgm.2026.109459_bib5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-16-0596","article-title":"Molecular mechanisms of resistance to First- and second-generation ALK inhibitors in ALK-rearranged lung cancer","volume":"6","author":"Gainor","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jmgm.2026.109459_bib6","article-title":"Targeting ALK rearrangements in NSCLC: current state of the art","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jmgm.2026.109459_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.11.004","article-title":"ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells","volume":"41","author":"Bergaggio","year":"2023","journal-title":"Cancer Cell"},{"issue":"Suppl 3","key":"10.1016\/j.jmgm.2026.109459_bib8","doi-asserted-by":"crossref","first-page":"iii42","DOI":"10.1093\/annonc\/mdw305","article-title":"Crizotinib resistance: implications for therapeutic strategies","volume":"27","author":"Dagogo-Jack","year":"2016","journal-title":"Ann. Oncol."},{"issue":"Suppl 3","key":"10.1016\/j.jmgm.2026.109459_bib9","doi-asserted-by":"crossref","first-page":"iii16","DOI":"10.1093\/annonc\/mdw302","article-title":"Precision medicine in NSCLC and pathology: how does ALK fit in the pathway?","volume":"27","author":"Kerr","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jmgm.2026.109459_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jjco\/hyaa192","article-title":"Brigatinib and lorlatinib: their effect on ALK inhibitors in NSCLC focusing on resistant mutations and central nervous system metastases","volume":"51","author":"Naito","year":"2021","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.jmgm.2026.109459_bib11","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jamaoncol.2021.3523","article-title":"Ensartinib vs crizotinib for patients with anaplastic lymphoma kinase-positive non-small cell lung cancer: a randomized clinical trial","volume":"7","author":"Horn","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jmgm.2026.109459_bib12","first-page":"447","article-title":"Structure-based virtual screening and molecular docking for the identification of potential multi-targeted inhibitors against breast cancer","volume":"9","author":"Yousuf","year":"2017","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jmgm.2026.109459_bib13","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1080\/07391102.2022.2123392","article-title":"Structure-based virtual screening, molecular docking, molecular dynamics simulation and MM\/PBSA calculations towards identification of steroidal and non-steroidal selective glucocorticoid receptor modulators","volume":"41","author":"Zare","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","article-title":"ADMET modeling approaches in drug discovery","volume":"24","author":"Ferreira","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmgm.2026.109459_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109459_bib17","first-page":"161","article-title":"A comprehensive electron wavefunction analysis toolbox for chemists, multiwfn","author":"Lu","year":"2024","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2026.109459_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/1120009X.2021.1937782","article-title":"Comparison of lorlatinib, alectinib and brigatinib in ALK inhibitor-naive\/untreated ALK-positive advanced non-small-cell lung cancer: a systematic review and network meta-analysis","volume":"34","author":"Wang","year":"2022","journal-title":"J. Chemother."},{"key":"10.1016\/j.jmgm.2026.109459_bib19","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/acs.jmedchem.1c00373","article-title":"Discovery of a brigatinib degrader SIAIS164018 with destroying metastasis-related oncoproteins and a reshuffling kinome profile","volume":"64","author":"Ren","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109459_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/10799893.2016.1212376","article-title":"Novel virtual lead identification in the discovery of hematopoietic cell kinase (HCK) inhibitors: application of 3D QSAR and molecular dynamics simulation","volume":"37","author":"Bavi","year":"2017","journal-title":"J. Recept. Signal Transduction"},{"key":"10.1016\/j.jmgm.2026.109459_bib21","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1080\/07391102.2020.1777899","article-title":"Structure-based virtual screening, pharmacokinetic prediction, molecular dynamics studies for the identification of novel EGFR inhibitors in breast cancer","volume":"39","author":"Anbuselvam","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib22","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/07391102.2020.1743758","article-title":"Identification of novel insect \u03b2-N-acetylhexosaminidase OfHex1 inhibitors based on virtual screening, biological evaluation, and molecular dynamics simulation","volume":"39","author":"Dong","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/08927022.2022.2123945","article-title":"Identification of potential CAMKK2 inhibitors based on virtual screening and molecular dynamics simulation","volume":"49","author":"Fu","year":"2023","journal-title":"Mol. Simul."},{"key":"10.1016\/j.jmgm.2026.109459_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fphar.2017.00889","article-title":"vNN web server for ADMET predictions","volume":"8","author":"Schyman","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109459_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","article-title":"ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database","volume":"10","author":"Dong","year":"2018","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2026.109459_bib26","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1080\/07391102.2017.1373706","article-title":"Identification of novel PPAR\u03b1\/\u03b3 dual agonists by virtual screening, ADMET prediction and molecular dynamics simulations","volume":"36","author":"Liu","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib27","unstructured":"Kaur, D., Daman, S., and Chopra, M. Identification of novel inhibitors of cancer target telomerase using a dual structure-based pharmacophore approach to virtually screen libraries, molecular docking and validation by molecular dynamics simulations. J. Biomol. Struct. Dyn. 1-24."},{"key":"10.1016\/j.jmgm.2026.109459_bib28","author":"Lu"},{"key":"10.1016\/j.jmgm.2026.109459_bib29","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1080\/07391102.2024.2313157","article-title":"3D-QSAR-based pharmacophore modelling of quinazoline derivatives for the identification of acetylcholinesterase inhibitors through virtual screening, molecular docking, molecular dynamics and DFT studies","volume":"43","author":"Kumar","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib30","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3390\/cancers11121826","article-title":"Molecular targeting therapy against EGFR family in breast cancer: progress and future potentials","volume":"11","author":"Maennling","year":"2019","journal-title":"Cancers."},{"key":"10.1016\/j.jmgm.2026.109459_bib31","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1080\/07391102.2016.1253503","article-title":"Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations","volume":"35","author":"Malik","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib32","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1080\/07391102.2020.1791957","article-title":"Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studies","volume":"39","author":"Mishra","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib33","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1080\/07391102.2020.1861982","article-title":"Molecular docking and dynamic simulation to identify potential phytocompound inhibitors for EGFR and HER2 as anti-breast cancer agents","volume":"40","author":"Prabhavathi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib34","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1080\/07391102.2021.1877823","article-title":"Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer","volume":"40","author":"Purawarga Matada","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/07391102.2021.2006086","article-title":"AMPA GluA2 subunit competitive inhibitors for PICK1 PDZ domain: pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation, and ADME studies","volume":"41","author":"Rathod","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109459_bib36","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1080\/07391102.2022.2152368","article-title":"Identification of new potent agonists for toll-like receptor 8 by virtual screening methods, molecular dynamics simulation, and MM-GBSA","volume":"41","author":"Sadeghkhani","year":"2023","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326001853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326001853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:40:35Z","timestamp":1782268835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326001853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S1093326326001853"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109459","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel anaplastic lymphoma kinase inhibitors with enhanced binding interactions for non-small cell lung cancer via in silico approaches and retrospective experimental data support","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109459"}}